The price-to-earnings ratio for Kiniksa Pharmaceuticals stock stands at 162.33 as of May 14, 2024. This is calculated based on the current EPS of $0.12 and the stock price of $19.48 per share.
Over the last two years, the average PE ratio of Kiniksa Pharmaceuticals has been 45.35. The current 162.33 PE ratio is comparable to the historical average. In the past two years, KNSA's PE ratio was at its highest in the Mar 2024 quarter at 164.42, with a price of $19.73 and an EPS of $0.12. The Mar 2023 quarter recorded the bottom point at 3.82, with a price of $10.76 and an EPS of $2.82.
Maximum annual increase: 1,446.74% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 87.7 | 1,446.74% |
| 2022 | 5.67 | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
Currently, KNSA's PE ratio is greater than its 3 and 5-year historical averages.
| Stock name | PE ratio | Market cap |
|---|---|---|
| KNSA Kiniksa Pharmaceuticals Ltd | 162.33 | $1.38B |
| OMER Omeros Corp | N/A | $243.36M |
| OMGA Omega Therapeutics Inc | N/A | $130.17M |
The price to earnings ratio for KNSA stock as of May 14, 2024, stands at 162.33.
Over the last 3 years, the average price to earnings ratio for KNSA stock is 45.35.
Over the last 5 years, the average price to earnings ratio for KNSA stock is 45.35.
Over the last two years, the quarterly PE ratio reached a historic high of 164.42 in the Mar 2024 quarter.
The current price to earnings ratio of KNSA is 258% higher than the 2-year historical average.
KNSA's PE ratio of 162.33 is considered high because the company's stock price is trading at a higher multiple of earnings.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (May 14, 2024), Kiniksa Pharmaceuticals's stock price is $19.48. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.12. Therefore, Kiniksa Pharmaceuticals's P/E ratio for today is 162.33. PE RATIO(162.33) = STOCK PRICE($19.48) / TTM EPS($0.12)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.